These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34076593)

  • 1. FragMAXapp: crystallographic fragment-screening data-analysis and project-management system.
    Lima GMA; Jagudin E; Talibov VO; Benz LS; Marullo C; Barthel T; Wollenhaupt J; Weiss MS; Mueller U
    Acta Crystallogr D Struct Biol; 2021 Jun; 77(Pt 6):799-808. PubMed ID: 34076593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FragMAX: the fragment-screening platform at the MAX IV Laboratory.
    Lima GMA; Talibov VO; Jagudin E; Sele C; Nyblom M; Knecht W; Logan DT; Sjögren T; Mueller U
    Acta Crystallogr D Struct Biol; 2020 Aug; 76(Pt 8):771-777. PubMed ID: 32744259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallographic fragment screening.
    Badger J
    Methods Mol Biol; 2012; 841():161-77. PubMed ID: 22222452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast fragment- and compound-screening pipeline at the Swiss Light Source.
    Kaminski JW; Vera L; Stegmann DP; Vering J; Eris D; Smith KML; Huang CY; Meier N; Steuber J; Wang M; Fritz G; Wojdyla JA; Sharpe ME
    Acta Crystallogr D Struct Biol; 2022 Mar; 78(Pt 3):328-336. PubMed ID: 35234147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AutoDrug: fully automated macromolecular crystallography workflows for fragment-based drug discovery.
    Tsai Y; McPhillips SE; González A; McPhillips TM; Zinn D; Cohen AE; Feese MD; Bushnell D; Tiefenbrunn T; Stout CD; Ludaescher B; Hedman B; Hodgson KO; Soltis SM
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):796-803. PubMed ID: 23633588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distributed computing for macromolecular crystallography.
    Krissinel E; Uski V; Lebedev A; Winn M; Ballard C
    Acta Crystallogr D Struct Biol; 2018 Feb; 74(Pt 2):143-151. PubMed ID: 29533240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REdiii: a pipeline for automated structure solution.
    Bohn MF; Schiffer CA
    Acta Crystallogr D Biol Crystallogr; 2015 May; 71(Pt 5):1059-67. PubMed ID: 25945571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin.
    Wollenhaupt J; Barthel T; Lima GMA; Metz A; Wallacher D; Jagudin E; Huschmann FU; Hauß T; Feiler CG; Gerlach M; Hellmig M; Förster R; Steffien M; Heine A; Klebe G; Mueller U; Weiss MS
    J Vis Exp; 2021 Mar; (169):. PubMed ID: 33749678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCP4 Cloud for structure determination and project management in macromolecular crystallography.
    Krissinel E; Lebedev AA; Uski V; Ballard CB; Keegan RM; Kovalevskiy O; Nicholls RA; Pannu NS; Skubák P; Berrisford J; Fando M; Lohkamp B; Wojdyr M; Simpkin AJ; Thomas JMH; Oliver C; Vonrhein C; Chojnowski G; Basle A; Purkiss A; Isupov MN; McNicholas S; Lowe E; Triviño J; Cowtan K; Agirre J; Rigden DJ; Uson I; Lamzin V; Tews I; Bricogne G; Leslie AGW; Brown DG
    Acta Crystallogr D Struct Biol; 2022 Sep; 78(Pt 9):1079-1089. PubMed ID: 36048148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native MS: an 'ESI' way to support structure- and fragment-based drug discovery.
    Vivat Hannah V; Atmanene C; Zeyer D; Van Dorsselaer A; Sanglier-Cianférani S
    Future Med Chem; 2010 Jan; 2(1):35-50. PubMed ID: 21426045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate macromolecular crystallographic refinement: incorporation of the linear scaling, semiempirical quantum-mechanics program DivCon into the PHENIX refinement package.
    Borbulevych OY; Plumley JA; Martin RI; Merz KM; Westerhoff LM
    Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1233-47. PubMed ID: 24816093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallographic fragment screening in academic cancer drug discovery.
    Martin MP; Endicott JA; Noble MEM; Tatum NJ
    Methods Enzymol; 2023; 690():211-234. PubMed ID: 37858530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast fragment and compound screening pipeline at the Swiss Light Source.
    Stegmann DP; Steuber J; Fritz G; Wojdyla JA; Sharpe ME
    Methods Enzymol; 2023; 690():235-284. PubMed ID: 37858531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput quantum-mechanics/molecular-mechanics (ONIOM) macromolecular crystallographic refinement with PHENIX/DivCon: the impact of mixed Hamiltonian methods on ligand and protein structure.
    Borbulevych O; Martin RI; Westerhoff LM
    Acta Crystallogr D Struct Biol; 2018 Nov; 74(Pt 11):1063-1077. PubMed ID: 30387765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frag4Lead: growing crystallographic fragment hits by catalog using fragment-guided template docking.
    Metz A; Wollenhaupt J; Glöckner S; Messini N; Huber S; Barthel T; Merabet A; Gerber HD; Heine A; Klebe G; Weiss MS
    Acta Crystallogr D Struct Biol; 2021 Sep; 77(Pt 9):1168-1182. PubMed ID: 34473087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of in situ diffraction in high-throughput structure determination platforms.
    Aller P; Sanchez-Weatherby J; Foadi J; Winter G; Lobley CM; Axford D; Ashton AW; Bellini D; Brandao-Neto J; Culurgioni S; Douangamath A; Duman R; Evans G; Fisher S; Flaig R; Hall DR; Lukacik P; Mazzorana M; McAuley KE; Mykhaylyk V; Owen RL; Paterson NG; Romano P; Sandy J; Sorensen T; von Delft F; Wagner A; Warren A; Williams M; Stuart DI; Walsh MA
    Methods Mol Biol; 2015; 1261():233-53. PubMed ID: 25502203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key factors for successful generation of protein-fragment structures requirement on protein, crystals, and technology.
    Böttcher J; Jestel A; Kiefersauer R; Krapp S; Nagel S; Steinbacher S; Steuber H
    Methods Enzymol; 2011; 493():61-89. PubMed ID: 21371587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines.
    McPhillips TM; McPhillips SE; Chiu HJ; Cohen AE; Deacon AM; Ellis PJ; Garman E; Gonzalez A; Sauter NK; Phizackerley RP; Soltis SM; Kuhn P
    J Synchrotron Radiat; 2002 Nov; 9(Pt 6):401-6. PubMed ID: 12409628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallographic analysis of TPP riboswitch binding by small-molecule ligands discovered through fragment-based drug discovery approaches.
    Warner KD; Ferré-D'Amaré AR
    Methods Enzymol; 2014; 549():221-33. PubMed ID: 25432751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MS methods to study macromolecule-ligand interaction: Applications in drug discovery.
    Riccardi Sirtori F; Altomare A; Carini M; Aldini G; Regazzoni L
    Methods; 2018 Jul; 144():152-174. PubMed ID: 29890284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.